Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts
- 12 November 1999
- journal article
- basic investigation
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 48 (4) , 447-453
- https://doi.org/10.1002/(sici)1522-726x(199912)48:4<447::aid-ccd23>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Preliminary Animal and Clinical Experiences Using an Electromechanical Endocardial Mapping Procedure to Distinguish Infarcted From Healthy MyocardiumCirculation, 1998
- Induction by Lysophosphatidylcholine, a Major Phospholipid Component of Atherogenic Lipoproteins, of Human Coronary Artery Smooth Muscle Cell MigrationCirculation, 1998
- Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth FactorsCirculation, 1998
- Feasibility and safety of percutaneous laser revascularization using the BiosenseTM system in porcine heartsCoronary Artery Disease, 1998
- Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.Cardiovascular Research, 1997
- A Novel Method for Nonfluoroscopic Catheter-Based Electroanatomical Mapping of the HeartCirculation, 1997
- Nonfluoroscopic, in vivo navigation and mapping technologyNature Medicine, 1996
- Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heartNature Medicine, 1996